Policymakers should tackle the consolidation of dialysis providers, as it could lead to negative downstream effects for Medicare Advantage beneficiaries, a study published Monday in Health Affairs suggested.
Researchers at the University of Southern California found three large Medicare Advantage insurers paid 127% of fee-for-service Medicare costs for dialysis treatment in 2016 and 2017. If the number of dialysis patients enrolling in…